We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
In our role overseeing the advertising of therapeutic goods, the TGA is very committed to supporting stakeholders to be able to meet their compliance obligations.
We have developed a range of educational material and activities to help our stakeholders understand their obligations under the Act, which we continue to adapt and refine as stakeholders provide feedback and as policies and legislation changes.
As well as formal educational training (such as face-to-face training sessions and webinars), the TGA website contains detailed information to assist advertisers. For more information, visit the Advertising Hub.
The TGA is currently developing guidance material relating to how businesses can:
- disseminate information to the public about their activities as medicinal cannabis manufactures
- provide information on services associated with stem cell therapy, or
- conduct disease education activities
without raising concerns under the advertising requirements set out in the Act.